> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Correction: FDA Says Baxter Clinolipid NDA Not Withdrawn
- URL: https://www.fdaweb.com/correction-fda-says-baxter-clinolipid-nda-not-withdrawn/
- Published: 2018-02-27T12:00:00.000Z
- Updated: 2026-09-14T23:25:51.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140853

*Federal Register* notice: FDA has corrected a 6/21/2017 *Federal Register* notice that announced the withdrawal of approval of 121 NDAs and 161 ANDAs from multiple applicants. A Baxter Healthcare NDA for Clinolipid 20% (olive oil and soybean oil) USP that was included in the original notice is now not withdrawn because the company notified the agency that the NDA should be kept active. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-02-27/pdf/2018-03925.pdf?ref=fdaweb.com).